Turn Therapeutics Inc.
TTRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Turn Therapeutics Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 8, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Turn Therapeutics Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-21 · GOLDEN ARTHUR F: Larger than all 8 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-11-17–2025-11-24: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2025-10-23–2025-10-23: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-12 | Chaudhary Zuraiz · See Remarks | Common Stock | P — Open market or private purchase | +2,500 | 3.50 | SEC filing |
| 2025-11-24 | GOLDEN ARTHUR F · Director | Common Stock | P — Open market or private purchase | +9,868 | 3.44 | SEC filing |
| 2025-11-21 | GOLDEN ARTHUR F · Director | Common Stock | P — Open market or private purchase | +20,532 | 2.87 | SEC filing |
| 2025-11-21 | Chaudhary Zuraiz · See Remarks | Common Stock | P — Open market or private purchase | +1,000 | 3.29 | SEC filing |
| 2025-11-20 | Chaudhary Zuraiz · See Remarks | Common Stock | P — Open market or private purchase | +1,450 | 2.61 | SEC filing |
| 2025-11-17 | Chaudhary Zuraiz · See Remarks | Common Stock | P — Open market or private purchase | +2,500 | 3.62 | SEC filing |
| 2025-10-23 | GOLDEN ARTHUR F · Director | Common Stock | P — Open market or private purchase | +20,202 | 4.95 | SEC filing |
| 2025-10-23 | Chesed Abraham · Other | Common Stock | P — Open market or private purchase | +14,286 | 4.60 | SEC filing |
Showing 8 of 9 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-04 | GOLDEN ARTHUR F · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +89,584 | SEC filing |
| 2026-06-04 | Gengos Andrew · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +95,000 | SEC filing |
| 2026-06-04 | Kester Kent Edward · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +83,334 | SEC filing |
| 2026-06-04 | Dewhurst Martin William · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +71,666 | SEC filing |
| 2026-05-28 | Burnam Bradley Evan · Chief Executive Officer | Common Stock | G — Bona fide gift | +300,000 | SEC filing |
| 2026-05-28 | Burnam Bradley Evan · Chief Executive Officer | Common Stock | G — Bona fide gift | −300,000 | SEC filing |
| 2026-04-02 | GOLDEN ARTHUR F · Director | Common Stock | G — Bona fide gift | +300,000 | SEC filing |
| 2026-04-02 | Burnam Bradley Evan · Chief Executive Officer | Common Stock | G — Bona fide gift | −300,000 | SEC filing |
Showing 8 of 14 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.